Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
Bauer L. LeSavage(Stanford University), Sarah C. Heilshorn(Stanford University), Katarina C. Klett(Stanford University), Christopher J. Long(University of Central Florida), Carla Huerta-López(Stanford University), Amber R. Smith(Stanford University), Kremena Karagyozova(Stanford University), Christina Curtis(Chan Zuckerberg Initiative (United States)), Kasper Karlsson(Karolinska Institutet), Paul L. Bollyky(Stanford Medicine), Brad A. Krajina(Rex Hospital), Calvin J. Kuo(Stratford University), D.H. Zhang(Stanford University), Christopher M. Madl(University of Pennsylvania), Aidan E. Gilchrist(Stanford University), Gernot Kaber(Stanford University), Michelle S. Huang(Stanford University)
Cited by 86
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
|The Journal of Experimental Medicine|2006|1.3k
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
|Proceedings of the National Academy of Sciences|2011|824